Who are Standard Fresh Whole Blood's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fresh frozen plasma, RBC, Dry plasma, FFP and Cryoprecipitate, Pathogen-Reduced Cryoprecipitate, Red Blood Cell Transfusion.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/standard-fresh-whole-blood.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Standard Fresh Whole Blood — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Standard Fresh Whole Blood (Standard Fresh Whole Blood) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Blood product. Area: Hematology/Transfusion Medicine.

phase 3 Blood product Hematology/Transfusion Medicine Biologic Live · refreshed every 30 min

Target snapshot

Standard Fresh Whole Blood (Standard Fresh Whole Blood) — Johns Hopkins University. Standard Fresh Whole Blood provides immediate restoration of oxygen-carrying capacity, clotting factors, and circulating volume in acute hemorrhage or severe anemia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Standard Fresh Whole Blood TARGET	Standard Fresh Whole Blood	Johns Hopkins University	phase 3	Blood product
Fresh frozen plasma	Fresh frozen plasma	Rigshospitalet, Denmark	marketed	Blood product / Plasma derivative
RBC	RBC	Asan Medical Center	marketed	Blood product
Dry plasma	Dry plasma	Vastra Gotaland Region	marketed	Blood product / Plasma derivative
FFP and Cryoprecipitate	FFP and Cryoprecipitate	The University of Texas Health Science Center, Houston	marketed	Blood product / Hemostatic agent
Pathogen-Reduced Cryoprecipitate	Pathogen-Reduced Cryoprecipitate	Weill Medical College of Cornell University	marketed	Blood product / Hemostatic agent
Red Blood Cell Transfusion	Red Blood Cell Transfusion	Rutgers, The State University of New Jersey	marketed	Blood product / Cellular therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Blood product class)

Asan Medical Center · 1 drug in this class
Johns Hopkins University · 1 drug in this class
Technische Universität Dresden · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Standard Fresh Whole Blood — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-fresh-whole-blood. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab